Literature DB >> 9691512

Side effects of morphine administration in cancer patients.

G Vanegas1, C Ripamonti, A Sbanotto, F De Conno.   

Abstract

According to the World Health Organization (WHO) guidelines, oral morphine is the first choice drug for treating moderate to severe cancer-related pain. The fear of the side effects caused by this drug and the scarce information about prevention and management of these effects are the main reasons for the underuse of morphine. The aim of this paper is to provide a review of the literature on the side effects most frequently present both in the titration phase and during chronic administration of oral morphine and to describe the appropriate treatment.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9691512     DOI： 10.1097/00002820-199808000-00011

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN： 0162-220X            Impact factor:   2.592


  10 in total

Review 1.  Management of opioid-induced bowel dysfunction in cancer patients.

Authors:  Antonio Cesar Tamayo; Paola Andrea Diaz-Zuluaga
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

Review 2.  Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem.

Authors:  Kirsten Auret; Stephan A Schug
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.

Authors:  Pamela R Tsuruda; Ross G Vickery; Daniel D Long; Scott R Armstrong; David T Beattie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-04       Impact factor: 3.000

4.  Effect of naloxone-3-glucuronide and N-methylnaloxone on the motility of the isolated rat colon after morphine.

Authors:  Peter Reber; Rudolf Brenneisen; Beatrice Flogerzi; Catarina Batista; Peter Netzer; Ulrich Scheurer
Journal:  Dig Dis Sci       Date:  2007-01-09       Impact factor: 3.199

Review 5.  Impact of prescribed medications on patient safety in older people.

Authors:  Sujo Anathhanam; Rachel A Powis; Alison L Cracknell; Jeremy Robson
Journal:  Ther Adv Drug Saf       Date:  2012-08

6.  Constipation in cancer patients on morphine.

Authors:  Joanne Droney; Joy Ross; Sophy Gretton; Ken Welsh; Hiroe Sato; Julia Riley
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

Review 7.  Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.

Authors:  Andrea Kurz; Daniel I Sessler
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.

Authors:  D T Beattie; M Cheruvu; N Mai; M O'Keefe; S Johnson-Rabidoux; C Peterson; E Kaufman; R Vickery
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-06       Impact factor: 3.000

9.  Opioid-prescribing Practices in Chronic Cancer Pain in a Tertiary Care Pain Clinic.

Authors:  Raghu S Thota; Pn Jain; Sumitra G Bakshi; Chhaya N Dhanve
Journal:  Indian J Palliat Care       Date:  2011-09

10.  Going beyond efficacy: strategies for cancer pain management.

Authors:  J Myers; N Shetty
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.